Literature DB >> 20599876

Significantly elevated C-reactive protein serum levels are associated with very high 30-day mortality rates in hospitalized medical patients.

Tamar Chundadze1, Arie Steinvil, Talya Finn, Hila Saranga, Hanan Guzner-Gur, Shlomo Berliner, Dan Justo, Yael Paran.   

Abstract

BACKGROUND: There is insufficient data regarding the differential diagnosis and the prognostic value of significantly elevated serum levels of C-reactive protein (CRP) in hospitalized medical patients. DESIGN AND METHODS: A retrospective review of medical charts of patients admitted to a tertiary hospital's Internal Medicine ward during a period of 1 year who had at least one CRP serum level measurement of 200mg/L or more.
RESULTS: Overall, 341 patients with a mean age of 69.8+/-1.0 years were included in the study. Acute infection was the most prevalent diagnosis (n=293; 85.9%) with community-acquired pneumonia being the most common acute infection (n=115; 33.7%). Non-infectious conditions accounted for 9.1% (n=31) of the diagnoses and included mainly malignant metastatic diseases (n=19; 5.6%). Overall, 70 (20.5%) patients died within 30 days of admission. Age and active malignancy, with metastasis or without metastasis, were independently associated with 30-day mortality.
CONCLUSION: Significantly elevated CRP serum levels are associated with bacterial infections, malignant diseases, and very high rates of 30-day mortality in hospitalized medical patients. Copyright (c) 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20599876     DOI: 10.1016/j.clinbiochem.2010.06.006

Source DB:  PubMed          Journal:  Clin Biochem        ISSN: 0009-9120            Impact factor:   3.281


  1 in total

1.  A second C-reactive protein (CRP) test to detect inflammatory burst in patients with acute bacterial infections presenting with a first relatively low CRP.

Authors:  Ilan Goldberg; Dana Shalmon; Ronen Shteinvil; Shlomo Berliner; Yael Paran; David Zeltser; Itzhak Shapira; Shani Shenhar-Tsarfaty; Ahuva Meilik; Asaf Wasserman; Ilana Goldiner; Tomer Ziv-Baran; Eli Sprecher; Tal Levinson; Ori Rogowski
Journal:  Medicine (Baltimore)       Date:  2020-10-16       Impact factor: 1.817

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.